The CARRA-Arthritis Foundation Flex Fund RFA supports pediatric rheumatic disease research projects affected by recent funding cuts, enabling completion of vital scientific aims.
Funder: Childhood Arthritis and Rheumatology Research Alliance
Due Dates: January 20, 2026 | May 18, 2026 | September 21, 2026
Funding Amounts: Up to $20,000 per award; project period is 1 year; 11 awards available per cycle.
Summary: Rapid supplemental funding for pediatric rheumatic disease research projects impacted by recent funding cuts.
Key Information: Only CARRA members with peer-reviewed projects that lost or had funding reduced in the past 12 months may apply.
The CARRA-Arthritis Foundation Flex Fund RFA is a rapid-response grant program designed to support pediatric rheumatic disease research projects that have experienced a reduction or termination of federal or other peer-reviewed funding within the past year. The goal is to provide timely supplemental resources to enable investigators to complete specific project aims or components, ensuring continuity of important research in the field. The program reflects CARRA's commitment to collaborative, investigator-driven research to advance the prevention, treatment, and cure of pediatric rheumatic diseases.